CD8A and neoplasm: Although cross-presentation of exogenous antigens by DCs plays a critical role in CD8+ T cell activation and effector function as we have recently demonstrated using a SA-4-1BBL-based vaccine [5], other non-professional antigen presenting cells conditioned by cytokines within the tumor microenvironment may also activate CD8+ T cells.